CA IX Antibodies

Santa Cruz Biotechnology provides a broad selection of CA IX monoclonal antibodies for detecting and analyzing carbonic anhydrase IX, a key enzyme involved in regulating pH and CO2 levels in tissues. CA IX monoclonal antibodies support various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Carbonic anhydrase IX plays a crucial role in tumor biology, particularly during hypoxia and acidosis, making it a significant marker for cancer diagnosis and prognosis. Its expression increases in various malignancies, contributing to tumor growth and metastasis by helping cancer cells adapt to their microenvironment. Understanding carbonic anhydrase IX function is essential for developing targeted therapies and improving patient outcomes. Researchers worldwide rely on CA IX monoclonal antibodies to investigate cellular mechanisms and pathways related to cancer progression. Advanced visualization techniques using fluorescent conjugates like horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) enable precise localization and quantification of carbonic anhydrase IX. Santa Cruz Biotechnology monoclonal antibodies for CA IX continue advancing cancer research and therapeutic development, supporting scientists in their quest to understand and combat various malignancies.